NO20054017L - 2-aryl-eddiksyrer, deres derivater og farmasoytisk sammensetninger som inneholder dem - Google Patents
2-aryl-eddiksyrer, deres derivater og farmasoytisk sammensetninger som inneholder demInfo
- Publication number
- NO20054017L NO20054017L NO20054017A NO20054017A NO20054017L NO 20054017 L NO20054017 L NO 20054017L NO 20054017 A NO20054017 A NO 20054017A NO 20054017 A NO20054017 A NO 20054017A NO 20054017 L NO20054017 L NO 20054017L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- acetic acids
- aryl acetic
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
Det er beskrevet utvalgte 2-aryleddiksyrer, deres derivater og farmasøytiske sammensetninger som inneholder disse forbindelsene som er nyttige til å inhibere kjemotaktisk aktivering av nøytrofiler (PMN-leukocytter) indusert ved interaksjon av interleukin-8 (IL-8) med CXCR1- og CXCR2-membranreseptorer. Forbindelsene til forhindring og behandling av patologier avledet fra nevnte aktivering. Særlig mangler 2(orto)-substituerte aryleddiksyrer og deres derivater, så som amider og sulfonamider, syklo-oksygenaseinhibisjonsaktivitet og er spesielt nyttig til behandling av nøytrofilavhengige patologier så som psoriasis, ulcererende kolitt, melanom, kronisk obstruktiv lungesykdom (COPD), bulløs pemfigoid, reumatoid artritt, idiopatisk fibrose, glomerulonefritt og til forhindring og behandling av skade forårsaket av ischemi og reperfusjon.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03002716 | 2003-02-06 | ||
PCT/EP2004/001021 WO2004069782A2 (en) | 2003-02-06 | 2004-02-04 | 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054017L true NO20054017L (no) | 2005-08-30 |
NO334149B1 NO334149B1 (no) | 2013-12-16 |
Family
ID=32842696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054017A NO334149B1 (no) | 2003-02-06 | 2005-08-30 | 2-aryl-eddiksyrer, deres derivater og farmasøytisk sammensetninger som inneholder dem |
Country Status (15)
Country | Link |
---|---|
US (3) | US7776909B2 (no) |
EP (1) | EP1590314B1 (no) |
JP (1) | JP5208411B2 (no) |
CN (1) | CN100562511C (no) |
AU (2) | AU2004210082B2 (no) |
CA (1) | CA2511582C (no) |
DK (1) | DK1590314T3 (no) |
ES (1) | ES2551929T3 (no) |
HK (1) | HK1090356A1 (no) |
HU (1) | HUE026285T2 (no) |
NO (1) | NO334149B1 (no) |
PT (1) | PT1590314E (no) |
RU (1) | RU2356887C2 (no) |
SI (1) | SI1590314T1 (no) |
WO (1) | WO2004069782A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2477604A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
CN1934077B (zh) * | 2004-03-23 | 2010-09-29 | 冬姆佩制药股份公司 | 2-苯基丙酸衍生物及含有它们的药物组合物 |
US8221804B2 (en) | 2005-02-03 | 2012-07-17 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
GB0525143D0 (en) * | 2005-12-09 | 2006-01-18 | Novartis Ag | Organic compounds |
GB0525144D0 (en) * | 2005-12-09 | 2006-01-18 | Novartis Ag | Organic compounds |
WO2009132051A1 (en) | 2008-04-21 | 2009-10-29 | Signum Biosciences, Inc. | Compounds, compositions and methods for making the same |
CN103159674A (zh) * | 2013-04-03 | 2013-06-19 | 苏州安诺生物医药技术有限公司 | 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途 |
CN107398233B (zh) * | 2016-05-20 | 2019-07-05 | 中国石油天然气股份有限公司 | 一种酰胺基苯磺酸盐表面活性剂及其制备方法和应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB119562A (en) * | 1917-10-22 | 1918-10-10 | William Davidson | Improvements in Implements for Cultivating or Pulverising the Soil. |
US2425821A (en) * | 1944-04-19 | 1947-08-19 | Paul A Peters | Method and apparatus for determining the eye color reflex sensation |
US2425721A (en) * | 1945-08-06 | 1947-08-19 | Univ Michigan | Thiophene compounds and methods of obtaining the same |
GB1148908A (en) * | 1965-04-19 | 1969-04-16 | Sumitomo Chemical Co | Indole derivatives and processes for making them |
FR8113M (no) * | 1967-07-26 | 1970-08-03 | ||
SE338993B (no) | 1967-07-26 | 1971-09-27 | Mcneilab Inc | |
US3752826A (en) * | 1970-01-26 | 1973-08-14 | Mcneilab Inc | Aroyl substituted pyrroles |
US3833608A (en) * | 1970-11-23 | 1974-09-03 | Merck Sharp & Dohme | Indole-3-methanesulfonamides |
US3883541A (en) * | 1971-02-22 | 1975-05-13 | Dow Chemical Co | 4-Amino-3,5,6-trichloro-2-(functionally substituted methyl) pyridine compounds |
AU5429699A (en) * | 1998-08-19 | 2000-03-14 | Theramark Limited | Drug targeting |
CN1384832A (zh) | 1999-11-18 | 2002-12-11 | 诺瓦提斯公司 | 作为农药的氨基杂环基酰胺化合物 |
IT1317826B1 (it) | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
US7135495B2 (en) * | 2000-03-09 | 2006-11-14 | Ono Pharmaceutical Co., Ltd. | Indole derivatives |
ITMI20010395A1 (it) * | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
WO2003013526A1 (en) | 2001-08-08 | 2003-02-20 | Merck & Co. Inc. | Anticoagulant compounds |
CA2459515A1 (en) * | 2001-09-07 | 2003-03-20 | Kazuhiko Torisu | Indole derivatives |
-
2004
- 2004-02-04 HU HUE04707926A patent/HUE026285T2/en unknown
- 2004-02-04 EP EP04707926.4A patent/EP1590314B1/en not_active Expired - Lifetime
- 2004-02-04 JP JP2006501731A patent/JP5208411B2/ja not_active Expired - Fee Related
- 2004-02-04 CN CNB2004800087419A patent/CN100562511C/zh not_active Expired - Fee Related
- 2004-02-04 WO PCT/EP2004/001021 patent/WO2004069782A2/en active Application Filing
- 2004-02-04 DK DK04707926.4T patent/DK1590314T3/en active
- 2004-02-04 AU AU2004210082A patent/AU2004210082B2/en not_active Ceased
- 2004-02-04 SI SI200432275T patent/SI1590314T1/sl unknown
- 2004-02-04 CA CA2511582A patent/CA2511582C/en not_active Expired - Fee Related
- 2004-02-04 RU RU2005127777/04A patent/RU2356887C2/ru not_active IP Right Cessation
- 2004-02-04 US US10/541,429 patent/US7776909B2/en not_active Expired - Fee Related
- 2004-02-04 ES ES04707926.4T patent/ES2551929T3/es not_active Expired - Lifetime
- 2004-02-04 PT PT47079264T patent/PT1590314E/pt unknown
-
2005
- 2005-08-30 NO NO20054017A patent/NO334149B1/no not_active IP Right Cessation
-
2006
- 2006-11-02 HK HK06112061.3A patent/HK1090356A1/xx not_active IP Right Cessation
-
2010
- 2010-06-30 US US12/828,181 patent/US8871784B2/en not_active Expired - Fee Related
-
2011
- 2011-03-22 AU AU2011201305A patent/AU2011201305B2/en not_active Ceased
- 2011-04-22 US US13/092,571 patent/US8648110B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1768026A (zh) | 2006-05-03 |
AU2011201305B2 (en) | 2013-01-31 |
US8871784B2 (en) | 2014-10-28 |
US20100267726A1 (en) | 2010-10-21 |
DK1590314T3 (en) | 2015-11-02 |
US20060223842A1 (en) | 2006-10-05 |
JP2006516592A (ja) | 2006-07-06 |
RU2356887C2 (ru) | 2009-05-27 |
WO2004069782A3 (en) | 2004-09-16 |
CA2511582A1 (en) | 2004-08-19 |
CN100562511C (zh) | 2009-11-25 |
EP1590314B1 (en) | 2015-08-05 |
US8648110B2 (en) | 2014-02-11 |
NO334149B1 (no) | 2013-12-16 |
AU2011201305A1 (en) | 2011-04-07 |
HUE026285T2 (en) | 2016-05-30 |
EP1590314A2 (en) | 2005-11-02 |
WO2004069782A2 (en) | 2004-08-19 |
SI1590314T1 (sl) | 2015-12-31 |
JP5208411B2 (ja) | 2013-06-12 |
US20110195967A1 (en) | 2011-08-11 |
CA2511582C (en) | 2012-01-24 |
US7776909B2 (en) | 2010-08-17 |
AU2004210082B2 (en) | 2011-03-17 |
AU2004210082A1 (en) | 2004-08-19 |
HK1090356A1 (en) | 2006-12-22 |
ES2551929T3 (es) | 2015-11-24 |
RU2005127777A (ru) | 2006-05-27 |
PT1590314E (pt) | 2015-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054017L (no) | 2-aryl-eddiksyrer, deres derivater og farmasoytisk sammensetninger som inneholder dem | |
CY1109687T1 (el) | Παραγωγα 2-φαινυλπροπιονικου οξεος και φαρμακευτικες συνθεσεις που τα περιεχουν | |
HK1089431A1 (en) | Sulfonic acids, their derivatives and pharmaceutical compositions containing them | |
Waelchli et al. | Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK | |
NO20032861L (no) | Heteroarylurea nevropeptid Y Y5-reseptorantagonister | |
DK1856031T3 (da) | 2-arylpropionsyrederivater og farmaceutiske sammensætninger indeholdende disse | |
Snow et al. | Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors | |
DE602006007012D1 (de) | Pyridinderivate als dipeptedyl-peptidase-hemmer | |
BRPI0515524A (pt) | compostos quìmicos | |
Wityak et al. | Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck | |
ATE484505T1 (de) | 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten | |
WO2005105092A3 (en) | 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity | |
MXPA04004744A (es) | Acidos 2-aril-propionicos y composiciones farmaceuticas que contienen a los mismo. | |
Shah et al. | A review on ROCK-II inhibitors: from molecular modelling to synthesis | |
Hatley et al. | The Design of Potent, Selective and Drug‐Like RGD αvβ1 Small‐Molecule Inhibitors Derived from non‐RGD α4β1 Antagonists | |
Crosignani et al. | Discovery of a novel series of CXCR3 antagonists | |
WO2005110409A3 (en) | Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity | |
DE602006007210D1 (de) | Metaboliten aus 2-arylpropionsäure-derivaten und pharmazeutische zusammensetzungen damit | |
Bauer et al. | Parallel synthesis and structure–activity relationships of a series of highly potent, selective, and neutral factor Xa inhibitors | |
CY1110691T1 (el) | 2-αρυλ-προπιονικα οξεα και φαρμακευτικες συνθεσεις που τα περιεχουν | |
TH87151A (th) | สารประกอบเคมี | |
Pierson et al. | Histamine-3 receptor inverse agonists for the treatment of obesity: validation of the target and identification of novel series | |
TH87151B (th) | สารประกอบเคมี | |
TH82154A (th) | อนุพันธ์ไพริโดไธอีโนไพริมิดีนชนิดใหม่ | |
TH93157A (th) | แอริลซัลโฟนิลโครแมนเป็นสารยับยั้ง 5-ht6 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: DOMPE FARMACEUTICI S.P.A., IT |
|
MM1K | Lapsed by not paying the annual fees |